Skip to main content
PMC home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 1999 Jun 22;13(4):173–179. doi: 10.1002/(SICI)1098-2825(1999)13:4<173::AID-JCLA6>3.0.CO;2-U

Inhibitory effect of free sialic acid on complement activation and its significance in hypocomplementemic glomerulonephritis

Takayuki Fujita 1,✉, Atsushi Satomura 1, Mutsuko Hidaka 1, Isao Ohsawa 1, Morito Endo 1, Hiroyuki Ohi 1
PMCID: PMC6807753  PMID: 10414597

Abstract

The role of free sialic acid on complement activation was investigated. The serum levels of free sialic acid and total sialic acid were measured by previously described methods in 16 patients with acute post‐infectious glomerulonephritis (AGN), 27 patients with systemic lupus erythematosus (SLE), 15 patients with persistent hypocomplementemic membranoproliferative glomerulonephritis (MPGN), and 13 healthy controls. A statistical study demonstrated an increased level of free sialic acid in patients with AGN and SLE in which the hypocomplementemia improved throughout the course and a decreased level of free sialic acid in patients with MPGN and SLE in which hypocomplementemia continued throughout the course. The levels of total sialic acid were significantly increased in patients with AGN and SLE and were significantly decreased in patients with MPGN. There was no correlation between the levels of free sialic acid and total sialic acid in patients with AGN, in whom the levels of both total and free sialic acids were increased. To examine the effect of free sialic acid on the complement cascade, lipopolysaccharide (LPS) was incubated with normal human serum (NHS) in the various concentrations of N‐acetyl neuraminic acid (NANA), a member of the sialic acid group. The incubation mixtures were examined by enzyme immunoassay using monoclonal anti‐iC3b antibody or anti‐Bb antibody. Native C3 or Factor B in NHS broke down less following the addition of NANA. To elucidate the role of NANA on the hemolytic function of C3, a rabbit erythrocyte (Ra E) hemolytic assay was carried out. Ra E lysed completely in the presence of R3 with native C3. However, hemolysis occurred to a lesser degree in C3‐depleted serum (R3) or R3 with NANA‐treated C3. To investigate the influence of NANA on complement components, the levels of complement components were measured in the incubation mixture with various doses of NANA and NHS. The levels of C3 and C5 were significantly decreased after the addition of NANA, even though the levels of Factor H and Factor I were not markedly changed. These data indicate that NANA exerts an influence on the complement components even though it has no effect on the regulatory proteins of complement. Our in vitro findings, together with the in vivo data, suggest that free sialic acid might have an inhibitory effect on the activation of C3 and the following complement cascade, and might also have been responsible for the improvement of hypocomplementemia. J. Clin. Lab. Anal. 13:173–179, 1999. © 1999 Wiley‐Liss, Inc.

Keywords: sialic acid, hypocomplementemia, acute post‐infectious glomerulonephritis, membranoproliferative glomerulonephritis, systemic lupus erythematosus

REFERENCES

  • 1. Leibowitch L, Halwachs M, Wattel S. Glomerulonephritis and hypocomplementemia: pathophysiology and pathogenic implications In: Hamburger J, Crosnier J, Grünfeld J, Maxwell MH, editors. Advances in Nephrology, vol. 9 Chicago: Year Book Medical Publishers; 1980. p 295–314. [PubMed] [Google Scholar]
  • 2. Ohi H. The role of complement in membrano‐proliferative glomerulonephritis (MPGN). Jpn J Nephrol 1987;20:1125–1139. [PubMed] [Google Scholar]
  • 3. Glassock RJ. Clinical features of immunologic glomerular disease In: Wilson CB, editor. Immunologic Mechanisms of Renal Disease. London: Churchill Livingstone; 1979. p 165–179. [Google Scholar]
  • 4. Fujita T. Clinical study of complement breakdown products in patients with hypocomplementemic glomerulonephritis. Jpn J Nephrol 1982; 24:845–853. [PubMed] [Google Scholar]
  • 5. Seki M, Ohi H, Kojima H, Fujita T, Hatano M. A case of Hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor. Jpn J Nephrol 1987;29:585–588. [PubMed] [Google Scholar]
  • 6. Fujita T, Ohi H, Seki M, Hatano M. Clinical evaluation and characterization of a unique C3 breakdown factor detected in a patient with acute glomerulonephritis. Nephron 1987;47:56–61. Medline [DOI] [PubMed] [Google Scholar]
  • 7. Schauer R. Chemistry, metabolism, and biological functions of sialic acids In: Tipson RS, Horton D, editors. Advances in Carbohydrate Chemistry and Biochemistry, vol. 40 London: Academic Press; 1982. p 131–234. [DOI] [PubMed] [Google Scholar]
  • 8. Shauer R. Sialic acids and their role as biological masks In: Hall J, editor. Trends in Biochemical Science, vol. 10 Amsterdam: Elsevier Science Publishers; 1985. p 357–360. [Google Scholar]
  • 9. Ourth DD, Bachinski LM. Bacterial sialic acid modulates activation of the alternative complement pathway of channel catfish. Develop Comp Immunol 1987;11:551–564.Medline [DOI] [PubMed] [Google Scholar]
  • 10. Pangburn MK, Müller‐Eberhard HJ. Complement C3 convertase: cell surface restriction of β1H control and generation of restriction on neuraminidase‐treated cells. Proc Natl Acad Sci U S A 1978;75:2416–2420. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Reutter W, Köttgen E, Bauer C, Gerok W. Biological significance of sialic acid In: Schauer R, editor. Sialic acids: chemistry, metabolism and function (Cell Biology Monograph, vol. 10). New York: Springer‐Verlag; 1980. p 263–305. [Google Scholar]
  • 12. Schauer R, Shukla AK, Schröder C, Müller E. The anti‐recognition function of sialic acid: studies with erythrocytes and macrophages. Pure Appl Chem 1984;56:907–921. [Google Scholar]
  • 13. Tack BF, Prahl JW. Fifth component of human complement: purification from plasma and polypeptide chain structure. Biochemistry 1976;15:4513–4521. Medline [DOI] [PubMed] [Google Scholar]
  • 14. Mancini G, Carbonara A, Hermans J. Immunological quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965;2:235–253. Medline [DOI] [PubMed] [Google Scholar]
  • 15. Tamerius JD, Pangburn MK, Müller‐Eberhard. Detection of a neoantigen on human iC3b and C3d by monoclonal antibody. J Immunol 1985;135:2015–2019. Medline [PubMed] [Google Scholar]
  • 16. Platts‐Mills TAE, Ishizaka K. Activation of the alternative pathway of human complement by rabbit cells. J Immunol 1974; 113:348–358. Medline [PubMed] [Google Scholar]
  • 17. Harrison RA, Lachmann PJ. Complement technology In: Weir DM, editor. Handbook of experimental immunology, 4th edition Oxford: Blackwell; 1986. p 5A.1–23.9. [Google Scholar]
  • 18. Hammond KS, Papermaster DS. Fluorometric assay of sialic acid in the picomole range: a modification of the thiobarbituric acid assay. Analyt Biochem 1976;74:292–297. Medline [DOI] [PubMed] [Google Scholar]
  • 19. Sugahara K, Sugimoto K, Nomura O, Usui T. Enzymatic assay of serum sialic acid. Clin Chim Acta 1980;108:493–498. Medline [DOI] [PubMed] [Google Scholar]
  • 20. Hess EL, Coburn AF, Bates RC, Murphy P. A new method for measuring sialic acid levels in serum and its application to rheumatic fever. J Clin Invest 1957;36:449–455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Pilatte Y, Bignon J, Lambré CR. Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity. Glycobiology 1993;3:201–217. Medline [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES